Universitätsklinikum des Saarlandes (UKS)

ATLAS: a phase 2, open-label study of rucaparib in patients with locally advanced (unresectable) or metastatic urothelial carcinoma (2018) Feyerabend S, Boegemann M, Goebell P, Stoeckle M, Nepert D, Wride K, Thomas D, et al. Conference contribution Multicentric analysis of the use behavior of cochlear implant users (2018) Oberhoffner T, Hoppe U, Hey M, Hecker D, Bagus H, Voigt P, Schicktanz S, et al. Journal article SUNNIFORECAST - A phase II study of Nivolumab in combination with Ipilimumab versus Standard of care in advanced or metastatic non-clear cell renal cell carcinoma (2018) Scheich S, Ahrens M, Goekbuget N, Boleti E, Burkholder , Escudier BJ, Goebell P, et al. Conference contribution Hyper-N-glycosylated SAMD14 and neurabin-I as driver autoantigens of primary central nervous system lymphoma (2018) Thurner L, Preuss KD, Bewarder M, Kemele M, Fadle N, Regitz E, Altmeyer S, et al. Journal article Defining therapy goals for major molecular remission in chronic myeloid leukemia: results of the randomized CML Study IV (2018) Saussele S, Hehlmann R, Fabarius A, Jeromin S, Proetel U, Rinaldetti S, Kohlbrenner K, et al. Journal article The POST trial: initial post-market experience of the Penumbra system: revascularization of large vessel occlusion in acute ischemic stroke in the United States and Europe (2018) Tarr R, Hsu D, Kulcsar Z, Bonvin C, Rufenacht D, Alfke K, Stingele R, et al. Journal article Characterization of Checkpoint Inhibitor-associated Diabetes mellitus - Experience in 12 Patients (2018) Satzger I, Momma M, Thoms KM, Eigentler T, Schultz E, Loquai C, Zimmer L, et al. Conference contribution Neuromuscular Side Effects of Immune Checkpoint Inhibitors (2018) Moreira A, Loquai C, Knauss S, Gutzmer R, Dimitriou F, Meier F, Heppt M, et al. Conference contribution Influence of previous Radiotherapy on the Success of an immune-oncologic Therapy in metastatic Melanoma - a retrospective multicenter Study of ADO (2018) Knispel S, Zimmer L, Gutzmer R, Heinzerling L, Weishaupt C, Pfoehler C, Gesierich A, et al. Conference contribution Factors increasing the risk for a severe reaction in anaphylaxis: An analysis of data from The European Anaphylaxis Registry (2018) Worm M, Francuzik W, Renaudin JM, Bilo MB, Cardona V, Hofmeier KS, Kohli A, et al. Journal article